FINADYNE VETERINARY

البلد: إسرائيل

اللغة: الإنجليزية

المصدر: Ministry of Health

العنصر النشط:

FLUNIXIN AS MEGLUMINE

متاح من:

INTERVET ( ISRAEL) LTD

الشكل الصيدلاني:

SOLUTION FOR INJECTION

تركيب:

FLUNIXIN AS MEGLUMINE 50 MG/ML

طريقة التعاطي:

I.M, I.V

نوع الوصفة الطبية :

Required

المصنعة من قبل:

SCHERING-PLOUGH SANTE ANIMALE, FRANCE

الخصائص العلاجية:

Horses: Finadyne solution is recommended for the alleviation of inflammation and pain associated with muscu-loskeletal disorders in the horse and for the alleviation of visceral pain associated with colic - as IV injection only. Cattle: Finadyne solution is recommended for the antipyretic effect in acute inflammatory conditions in cattle - as IV injection only. Pigs: Sow mamilliary metritis agalactia syndrome - as IM injection only.

تاريخ الترخيص:

2020-12-31

نشرة المعلومات

CONSUMER PACKAGE INSERT FOR VETERINARY MEDICINAL PRODUCT
This product is marketed with a veterinarian’s prescription only
For animal use only
1.
NAME OF THE VETERINARY MEDICINAL PRODUCT, ITS FORM AND
STRENGTH
FINADYNE VETERINARY
Solution for Injection
2.
ACTIVE INGREDIENT/S:
Flunixin (as meglumine) 5.0% w/v
Preservative: Phenol 0.50% w/v
A list of inactive ingredients is detailed in section 13 - "Further
Information".
3.
WHAT IS THE MEDICINE INTENDED FOR:
Horses:
For
the
alleviation
of
inflammatory
pain
associated
with
musculoskeletal
disorders and for the alleviation of visceral pain associated with
colic.
Cattle: As an antipyretic for respiratory disease in cattle.
Pigs: Mammilliary metritis agalactia syndrome.
4.
CONTRAINDICATIONS:
- Do not use in case of sensitivity to any of the ingredients.
- Do not exceed the recommended dose or the duration of treatment.
- Do not use in case of cardiac, hepatic or renal diseases.
- Do not use in case of possible gastro-intestinal ulceration or
bleeding.
- Do not administer to pregnant mares.
- Do not treat pregnant sows or those intended for breeding.
- Do not use in cattle within 48 hours preceding expected parturition
time.
5.
SIDE EFFECTS:
Finadyne Veterinary is a medicine from the NSAIDs - non-steroidal
anti-inflammatory
drug group. Untoward effects can include digestive system irritation,
peptic ulcers,
and, in dehydrated or hypovolemic (low plasma level) animals, there is
a risk of renal
damage.
In pigs local irritation may occur at the injection site. This effect
resolves spontaneously
within 14 days.
If you notice any serious effects or other effects not mentioned in
this leaflet, please
inform your veterinary surgeon.
Side effects can be reported to the Ministry of Health by clicking on
the link “Report
Side Effects of Drug Treatment” found on the Ministry of Health
homepage
(www.health.gov.il) that directs you to the online form for reporting
side effects, or by
entering the link:
https://sideeffects.health.gov.il/
6.
TARGET ANIMALS:
Horses, cattle, pigs.

خصائص المنتج

1
SUMMARY OF PRODCUT CHARASTERISTICS
1.
NAME OF VETERINARY MEDICINAL PRODUCT
Finadyne Veterinary
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
Active substance:
Flunixin (as meglumine)
50 mg/ml
Excipients:
Phenol (preservative)
5 mg/ml
For the full list of excipients, see section 6.1.
3.
PHARMACEUTICAL FORM
Solution for injection.
4.
CLINICAL PARTICULARS
4.1.
Target species
Cattle, horses and pigs.
4.2.
Indications for use, specifying the target species
In Cattle:
For the antipyretic effect in acute inflammatory conditions.
In Horses:
For the alleviation of inflammation and pain associated with
musculo-skeletal
disorders.
For the alleviation of visceral pain associated with colic.
In Pigs: Sow mamilliary metritis agalactia syndrome.
4.3.
Contra-indications
Do not exceed the stated dose or the duration of treatment.
Use is contra-indicated in animals suffering from cardiac, hepatic or
renal
disease, where there is the possibility of gastro-intestinal
ulceration or bleeding,
or where there is hypersensitivity to the product.
Do not use the product within 48 hours before expected parturition in
cows.
Do not administer to pregnant mares.
Do not administer to pregnant sows, gilts at mating and in breeding
boars.
Hypersensitivity to the active substance or to any of the excipients
listed in
section 6.1.
2
4.4.
Special warning for each target species
Non-steroidal, anti-inflammatory drugs are not permitted under the
rules of
Racing and under rules covering other competitive events.
The Royal College of Veterinary Surgeons has given advice to the
Veterinary
Profession regarding the use of anti-inflammatory drugs in competing
horses. It
states that “if a veterinarian recommends the discontinuation of any
such drug
not less than eight days before racing, he should feel sure that he
has catered
for all but the most exceptional case”.
Do not exceed the recommended dose or duration of treatment.
4.5.
Special precautions for use
_ _
i)
Special precautions for use in animals
Avoid intra-arterial injection.
Inject slowly as li